Discovery of cariprazine (RGH-188): A novel antipsychotic acting on dopamine D3/D2 receptors

被引:70
|
作者
Agai-Csongor, Eva [1 ]
Domany, Gyoergy [1 ]
Nogradi, Katalin [1 ]
Galambos, Janos [1 ]
Vago, Istvan [1 ]
Keseru, Gyoergy Miklos [1 ]
Greiner, Istvan [1 ]
Laszlovszky, Istvan [1 ]
Gere, Aniko [1 ]
Schmidt, Eva [1 ]
Kiss, Bela [1 ]
Vastag, Monika [1 ]
Tihanyi, Karoly [1 ]
Saghy, Katalin [1 ]
Laszy, Judit [1 ]
Gyertyan, Istvan [1 ]
Zajer-Balazs, Maria [1 ]
Gemesi, Larisza [1 ]
Kapas, Margit [1 ]
Szombathelyi, Zsolt [1 ]
机构
[1] Gedeon Richter Plc, H-1475 Budapest 10, Hungary
关键词
Cariprazine; RGH-188; Dopamine D-3 and D-2 ligands; Antipsychotic; Chloro-scan; IN-VIVO; EFFICACY; RG-15;
D O I
10.1016/j.bmcl.2012.03.104
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Medicinal chemistry optimization of an impurity isolated during the scale-up synthesis of a pyridylsulfonamide type dopamine D-3/D-2 compound (1) led to a series of new piperazine derivatives having affinity to both dopamine D-3 and D-2 receptors. Several members of this group showed excellent pharmacokinetic and pharmacodynamic properties as demonstrated by outstanding activities in different antipsychotic tests. The most promising representative, 2m (cariprazine) had good absorption, excellent brain penetration and advantageous safety profile. Based on its successful clinical development we are looking forward to the NDA filing of cariprazine in 2012. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3437 / 3440
页数:4
相关论文
共 50 条
  • [1] Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents
    Gyertyan, Istvan
    Kiss, Bela
    Saghy, Katalin
    Laszy, Judit
    Szabo, Gyoergyi
    Szabados, Tamas
    Gemesi, Larisza I.
    Pasztor, Gabriella
    Zajer-Balazs, Maria
    Kapas, Margit
    Csongor, Eva Agai
    Domany, Gyoergy
    Tihanyi, Karoly
    Szombathelyi, Zsolt
    NEUROCHEMISTRY INTERNATIONAL, 2011, 59 (06) : 925 - 935
  • [2] RGH-188, a d3/d2 dopamine receptor antagonist/partial agonist atypical antipsychotic candidate
    Laszlovszky, I.
    Kiss, B.
    Gyertyan, I.
    Meszaros, G. Pasztor
    Seneca, N.
    Schmidt, E.
    Nemethy, Z. S.
    Bugovics, G. Y.
    Saghy, K.
    Laszy, J.
    Kapas, M.
    Nemeth, G. Y.
    Szombathelyi, Z. S.
    EUROPEAN PSYCHIATRY, 2008, 23 : S163 - S163
  • [3] Pharmacokinetics of RGH-188, a novel dopamine D3/D2 antagonist/partial agonist atypical antipsychotic, in rats and dogs
    Meszaros, G. Pasztor
    Bolf, E. Terjeki
    Gemesi, L.
    Kapas, M.
    Tihanyi, K.
    Szombathelyi, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S456 - S457
  • [4] Pharmacological profile of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist atypical antipsychotic
    Gyertyan, I.
    Kiss, B.
    Saghy, K.
    Laszlovszky, I.
    Horvath, A.
    Laszy, J.
    Schmidt, E.
    Szabo, G.
    Domany, G.
    Csongor, E. Agai
    Tihanyi, K.
    Szombathelyi, Z.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S432 - S432
  • [5] RGH-188, an atypical antipsychotic with dopamine D3/D2 antagonist/partial agonist properties:: In vitro characterisation
    Kiss, B.
    Laszlovszky, I.
    Horvath, A.
    Schmidt, E.
    Bugovics, Gy.
    Orosz, Sz.
    Hornok, K.
    Gyertyan, I.
    Agai-Csongor, E.
    Domany, Gy.
    Tihanyi, K.
    Szombathelyi, Zs.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S221 - S222
  • [6] Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
    Kiss, Bela
    Horvath, Attila
    Nemethy, Zsolt
    Schmidt, Eva
    Laszlovszky, Istvan
    Bugovics, Gyula
    Fazekas, Karoly
    Hornok, Katalin
    Orosz, Szabolcs
    Gyertyan, Istvan
    Agai-Csongor, Eva
    Domany, Gyoergy
    Tihanyi, Karoly
    Adham, Nika
    Szombathelyi, Zsolt
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 333 (01): : 328 - 340
  • [7] RGH-188, an atypical antipsychotic with dopamine D3/D2 antagonist/partial agonist properties:: Neurochemical characterisation
    Kiss, B.
    Gyertyan, I.
    Agai-Csongor, E.
    Domany, Gy.
    Tihanyi, K.
    Szombathelyi, Zs.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S222 - S222
  • [8] Cariprazine (RGH-188), a Potential Antipsychotic with Dopamine D3/D2 Functional Antagonist Properties, Attenuates Manic-Like Behaviors in Animal Models
    Adham, Nika
    Samoriski, Gary
    Gao, Yonglin
    Hougland, Tyler
    Lei, Zhenmin
    El-Mallakh, Rif S.
    Kiss, Bela
    Szombathelyi, Zsolt
    Gyertyan, Istvan
    BIOLOGICAL PSYCHIATRY, 2009, 65 (08) : 205S - 206S
  • [9] RGH-188, an atypical antipsychotic with dopamine D3/D2 antagonist/partial agonist properties:: Behavioral characterisation
    Gyertyan, I.
    Kiss, B.
    Saghy, K.
    Laszy, J.
    Szabo, Gy.
    Agai-Csongor, E.
    Domany, Gy.
    Tihanyi, K.
    Szombathelyi, Zs.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S222 - S222
  • [10] Favourable behavioural actions of RGH-188, a novel dopamine D3/D2 receptor antagonist/partial agonist antipsychotic candidate
    Gyertyan, I.
    Kiss, B.
    Saghy, K.
    Laszy, J.
    Szabo, G.
    Agai-Csongor, E.
    Domany, G.
    Tihanyi, K.
    Szombathelyi, Z.
    BEHAVIOURAL PHARMACOLOGY, 2007, 18 : S12 - S13